Quantitative analysis of myocardial kinetics of 15-p-[iodine-125]iodophenylpentadecanoic acid

Timothy R DeGrado, J. E. Holden, C. K. Ng, D. M. Raffel, S. J. Gatley

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Myocardial extraction and the characteristic tissue clearance of radioactivity following bolus injections of a radioiodinated (125I) long chain fatty acid (LCFA) analog 15-p-iodophenylpentadecanoic acid (IPPA) were examined in the isolated perfused working rat heart. Radioactivity remaining in the heart was monitored with external scintillation probes. A compartmental model which included nonesterified tracer, catabolite, and complex lipid compartments successfully fitted tissue time-radioactivity residue curves, and gave a value for the rate of IPPA oxidation 1.8 times that obtained from steady-state release of tritiated water from labeled palmitic acid. The technique was sensitive to the impairment of LCFA oxidation in hearts of animals treated with the carnitine palmitoyltransferase I inhibitor, 2[5-(4-chlorophenyl)pentyl]oxirane-2-carboxylate (POCA). IPPA or similar modified fatty acids may be better than 11C-labeled physiological fatty acids such as palmitate in this type of study, because efflux of unoxidized tracer and catabolite(s) from the heart are kinetically more distinct, and their contributions to the early data can be reliably separated. This technique may be suitable for extension to in vivo measurements with positron tomography and appropriate modified fatty acids.

Original languageEnglish (US)
Pages (from-to)1211-1218
Number of pages8
JournalJournal of Nuclear Medicine
Volume30
Issue number7
StatePublished - 1989
Externally publishedYes

Fingerprint

Iodine
Fatty Acids
Acids
Radioactivity
Carnitine O-Palmitoyltransferase
Ethylene Oxide
Palmitic Acid
Palmitates
Tomography
Electrons
Lipids
Injections
Water

ASJC Scopus subject areas

  • Radiological and Ultrasound Technology

Cite this

Quantitative analysis of myocardial kinetics of 15-p-[iodine-125]iodophenylpentadecanoic acid. / DeGrado, Timothy R; Holden, J. E.; Ng, C. K.; Raffel, D. M.; Gatley, S. J.

In: Journal of Nuclear Medicine, Vol. 30, No. 7, 1989, p. 1211-1218.

Research output: Contribution to journalArticle

DeGrado, TR, Holden, JE, Ng, CK, Raffel, DM & Gatley, SJ 1989, 'Quantitative analysis of myocardial kinetics of 15-p-[iodine-125]iodophenylpentadecanoic acid', Journal of Nuclear Medicine, vol. 30, no. 7, pp. 1211-1218.
DeGrado, Timothy R ; Holden, J. E. ; Ng, C. K. ; Raffel, D. M. ; Gatley, S. J. / Quantitative analysis of myocardial kinetics of 15-p-[iodine-125]iodophenylpentadecanoic acid. In: Journal of Nuclear Medicine. 1989 ; Vol. 30, No. 7. pp. 1211-1218.
@article{cdadb03654a04a86bb0e77fb3e945290,
title = "Quantitative analysis of myocardial kinetics of 15-p-[iodine-125]iodophenylpentadecanoic acid",
abstract = "Myocardial extraction and the characteristic tissue clearance of radioactivity following bolus injections of a radioiodinated (125I) long chain fatty acid (LCFA) analog 15-p-iodophenylpentadecanoic acid (IPPA) were examined in the isolated perfused working rat heart. Radioactivity remaining in the heart was monitored with external scintillation probes. A compartmental model which included nonesterified tracer, catabolite, and complex lipid compartments successfully fitted tissue time-radioactivity residue curves, and gave a value for the rate of IPPA oxidation 1.8 times that obtained from steady-state release of tritiated water from labeled palmitic acid. The technique was sensitive to the impairment of LCFA oxidation in hearts of animals treated with the carnitine palmitoyltransferase I inhibitor, 2[5-(4-chlorophenyl)pentyl]oxirane-2-carboxylate (POCA). IPPA or similar modified fatty acids may be better than 11C-labeled physiological fatty acids such as palmitate in this type of study, because efflux of unoxidized tracer and catabolite(s) from the heart are kinetically more distinct, and their contributions to the early data can be reliably separated. This technique may be suitable for extension to in vivo measurements with positron tomography and appropriate modified fatty acids.",
author = "DeGrado, {Timothy R} and Holden, {J. E.} and Ng, {C. K.} and Raffel, {D. M.} and Gatley, {S. J.}",
year = "1989",
language = "English (US)",
volume = "30",
pages = "1211--1218",
journal = "Journal of Nuclear Medicine",
issn = "0161-5505",
publisher = "Society of Nuclear Medicine Inc.",
number = "7",

}

TY - JOUR

T1 - Quantitative analysis of myocardial kinetics of 15-p-[iodine-125]iodophenylpentadecanoic acid

AU - DeGrado, Timothy R

AU - Holden, J. E.

AU - Ng, C. K.

AU - Raffel, D. M.

AU - Gatley, S. J.

PY - 1989

Y1 - 1989

N2 - Myocardial extraction and the characteristic tissue clearance of radioactivity following bolus injections of a radioiodinated (125I) long chain fatty acid (LCFA) analog 15-p-iodophenylpentadecanoic acid (IPPA) were examined in the isolated perfused working rat heart. Radioactivity remaining in the heart was monitored with external scintillation probes. A compartmental model which included nonesterified tracer, catabolite, and complex lipid compartments successfully fitted tissue time-radioactivity residue curves, and gave a value for the rate of IPPA oxidation 1.8 times that obtained from steady-state release of tritiated water from labeled palmitic acid. The technique was sensitive to the impairment of LCFA oxidation in hearts of animals treated with the carnitine palmitoyltransferase I inhibitor, 2[5-(4-chlorophenyl)pentyl]oxirane-2-carboxylate (POCA). IPPA or similar modified fatty acids may be better than 11C-labeled physiological fatty acids such as palmitate in this type of study, because efflux of unoxidized tracer and catabolite(s) from the heart are kinetically more distinct, and their contributions to the early data can be reliably separated. This technique may be suitable for extension to in vivo measurements with positron tomography and appropriate modified fatty acids.

AB - Myocardial extraction and the characteristic tissue clearance of radioactivity following bolus injections of a radioiodinated (125I) long chain fatty acid (LCFA) analog 15-p-iodophenylpentadecanoic acid (IPPA) were examined in the isolated perfused working rat heart. Radioactivity remaining in the heart was monitored with external scintillation probes. A compartmental model which included nonesterified tracer, catabolite, and complex lipid compartments successfully fitted tissue time-radioactivity residue curves, and gave a value for the rate of IPPA oxidation 1.8 times that obtained from steady-state release of tritiated water from labeled palmitic acid. The technique was sensitive to the impairment of LCFA oxidation in hearts of animals treated with the carnitine palmitoyltransferase I inhibitor, 2[5-(4-chlorophenyl)pentyl]oxirane-2-carboxylate (POCA). IPPA or similar modified fatty acids may be better than 11C-labeled physiological fatty acids such as palmitate in this type of study, because efflux of unoxidized tracer and catabolite(s) from the heart are kinetically more distinct, and their contributions to the early data can be reliably separated. This technique may be suitable for extension to in vivo measurements with positron tomography and appropriate modified fatty acids.

UR - http://www.scopus.com/inward/record.url?scp=0024332581&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024332581&partnerID=8YFLogxK

M3 - Article

C2 - 2738702

AN - SCOPUS:0024332581

VL - 30

SP - 1211

EP - 1218

JO - Journal of Nuclear Medicine

JF - Journal of Nuclear Medicine

SN - 0161-5505

IS - 7

ER -